MARK H MD RACHESKY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK H MD RACHESKY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK H MD RACHESKY. MARK H MD RACHESKY is Director in EMISPHERE TECHNOLOGIES INC ($EMIS) and Director in NAVISTAR INTERNATIONAL CORP ($NAV) and Director in TITAN INTERNATIONAL INC ($TWI) and Director in LORAL SPACE & COMMUNICATIONS INC. ($LORL) and Director in LIONS GATE ENTERTAINMENT CORP /CN/ ($LGF).
Latest Insider Trading Transactions of MARK H MD RACHESKY
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EMIS, LGF, LORL, NAV, TWI
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2021 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 767 | 0 | 52,638 | 51.9 K to 52.6 K (+1.48 %) |
Mar 04 2021 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 3,389 | 0 | 51,871 | 48.5 K to 51.9 K (+6.99 %) |
Dec 16 2020 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | M | 39.32 | 5,000 | 196,600 | 0 | |
Dec 16 2020 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Payment of Exercise | F | 44.18 | 4,450 | 196,601 | 47,714 | 52.2 K to 47.7 K (-8.53 %) |
Dec 16 2020 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | M | 39.32 | 5,000 | 196,600 | 52,164 | 47.2 K to 52.2 K (+10.60 %) |
Oct 05 2020 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 8.52 | 2,089 | 17,798 | 54,706 | 52.6 K to 54.7 K (+3.97 %) |
Oct 05 2020 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 9.26 | 1,922 | 17,798 | 53,323 | 51.4 K to 53.3 K (+3.74 %) |
Oct 02 2020 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 775 | 0 | 47,164 | 46.4 K to 47.2 K (+1.67 %) |
Sep 17 2020 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 8.89 | 2,812 | 24,999 | 2,812 | 0 to 2.8 K |
Sep 17 2020 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 9.64 | 2,593 | 24,997 | 2,593 | 0 to 2.6 K |
Jun 17 2020 | TWI | TITAN INTERNATIONA ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 105,263 | 0 | 105,263 | 0 to 105.3 K |
May 06 2020 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 7.22 | 81,967 | 592,130 | 3,242,547 | 3.2 M to 3.2 M (+2.59 %) |
May 06 2020 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 7.00 | 100,000 | 699,920 | 3,160,580 | 3.1 M to 3.2 M (+3.27 %) |
Apr 03 2020 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 5.64 | 7,518 | 42,402 | 51,130 | 43.6 K to 51.1 K (+17.24 %) |
Apr 03 2020 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 6.08 | 6,973 | 42,396 | 49,999 | 43 K to 50 K (+16.21 %) |
Apr 02 2020 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 2,047 | 0 | 45,192 | 43.1 K to 45.2 K (+4.74 %) |
Mar 17 2020 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 4.84 | 215,013 | 1,039,631 | 3,060,580 | 2.8 M to 3.1 M (+7.56 %) |
Mar 17 2020 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 4.73 | 266,009 | 1,258,036 | 2,845,567 | 2.6 M to 2.8 M (+10.31 %) |
Mar 17 2020 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 4.83 | 261,597 | 1,262,598 | 2,579,558 | 2.3 M to 2.6 M (+11.29 %) |
Mar 17 2020 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 4.83 | 46,701 | 225,402 | 128,311 | 81.6 K to 128.3 K (+57.22 %) |
Feb 27 2020 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 4,125 | 0 | 43,145 | 39 K to 43.1 K (+10.57 %) |
Dec 11 2019 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | M | 21.02 | 5,000 | 105,075 | 0 | |
Dec 11 2019 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | M | 21.02 | 5,000 | 105,075 | 37,724 | 32.7 K to 37.7 K (+15.28 %) |
Oct 03 2019 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 9.19 | 2,317,961 | 21,302,062 | 2,317,961 | 0 to 2.3 M |
Oct 03 2019 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 9.19 | 81,610 | 749,996 | 81,610 | 0 to 81.6 K |
Oct 03 2019 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 8.81 | 1,941 | 17,100 | 43,612 | 41.7 K to 43.6 K (+4.66 %) |
Oct 03 2019 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 9.34 | 1,831 | 17,102 | 43,026 | 41.2 K to 43 K (+4.44 %) |
Oct 02 2019 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 1,334 | 0 | 32,724 | 31.4 K to 32.7 K (+4.25 %) |
Sep 17 2019 | TWI | TITAN INTERNATIONA ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 61,855 | 0 | 61,855 | 0 to 61.9 K |
Sep 12 2019 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 10.31 | 2,425 | 25,002 | 2,425 | 0 to 2.4 K |
Sep 12 2019 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 10.31 | 2,425 | 25,002 | 2,425 | 0 to 2.4 K |
Sep 12 2019 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 11.03 | 2,267 | 25,005 | 2,267 | 0 to 2.3 K |
Sep 12 2019 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 11.03 | 2,267 | 25,005 | 2,267 | 0 to 2.3 K |
Jul 02 2019 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 1,089 | 0 | 31,390 | 30.3 K to 31.4 K (+3.59 %) |
Apr 03 2019 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 14.91 | 2,844 | 42,404 | 40,585 | 37.7 K to 40.6 K (+7.54 %) |
Apr 03 2019 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 15.51 | 2,733 | 42,389 | 40,141 | 37.4 K to 40.1 K (+7.31 %) |
Apr 03 2019 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 1,161 | 0 | 30,301 | 29.1 K to 30.3 K (+3.98 %) |
Mar 04 2019 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | M | 0.00 | 3,207 | 0 | 0 | |
Mar 04 2019 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | M | 0.00 | 3,206 | 0 | 29,140 | 25.9 K to 29.1 K (+12.36 %) |
Dec 21 2018 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 14.06 | 19,331 | 271,873 | 193,816 | 174.5 K to 193.8 K (+11.08 %) |
Dec 21 2018 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 13.99 | 33,288 | 465,789 | 174,485 | 141.2 K to 174.5 K (+23.58 %) |
Dec 21 2018 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 14.47 | 47,889 | 692,954 | 141,197 | 93.3 K to 141.2 K (+51.32 %) |
Dec 21 2018 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 14.06 | 130,669 | 1,837,742 | 1,377,775 | 1.2 M to 1.4 M (+10.48 %) |
Dec 21 2018 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 13.99 | 225,012 | 3,148,525 | 1,247,106 | 1 M to 1.2 M (+22.01 %) |
Dec 21 2018 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | P | 14.47 | 323,711 | 4,684,098 | 1,022,094 | 698.4 K to 1 M (+46.35 %) |
Dec 13 2018 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 27.31 | 5,000 | 136,550 | 5,000 | |
Dec 13 2018 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 27.31 | 5,000 | 136,550 | 5,000 | |
Oct 03 2018 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 21.20 | 701 | 14,861 | 37,741 | 37 K to 37.7 K (+1.89 %) |
Oct 03 2018 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 22.49 | 661 | 14,866 | 37,408 | 36.7 K to 37.4 K (+1.80 %) |
Oct 02 2018 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.00 | 812 | 0 | 812 | |
Sep 13 2018 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 21.30 | 1,174 | 25,006 | 1,174 | 0 to 1.2 K |
Sep 13 2018 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 22.42 | 1,115 | 24,998 | 1,115 | 0 to 1.1 K |
Jul 03 2018 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.00 | 767 | 0 | 767 | |
Jun 15 2018 | TWI | TITAN INTERNATIONA ... | RACHESKY MARK H MD | Director | Option Exercise | A | 11.85 | 20,000 | 236,900 | 20,000 | |
Apr 04 2018 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 24.24 | 1,733 | 42,008 | 36,129 | 34.4 K to 36.1 K (+5.04 %) |
Apr 04 2018 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 25.98 | 1,617 | 42,010 | 35,849 | 34.2 K to 35.8 K (+4.72 %) |
Apr 03 2018 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.00 | 323 | 0 | 323 | |
Apr 03 2018 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Grant | A | 34.97 | 571 | 19,968 | 25,934 | 25.4 K to 25.9 K (+2.25 %) |
Mar 02 2018 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | M | 0.00 | 3,087 | 0 | 0 | |
Mar 02 2018 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | M | 0.00 | 3,087 | 0 | 0 | |
Mar 02 2018 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | M | 0.00 | 3,086 | 0 | 25,363 | 22.3 K to 25.4 K (+13.85 %) |
Mar 02 2018 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | M | 0.00 | 3,086 | 0 | 25,363 | 22.3 K to 25.4 K (+13.85 %) |
Jan 03 2018 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.00 | 729 | 0 | 729 | |
Dec 14 2017 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 41.63 | 5,000 | 208,150 | 5,000 | |
Oct 04 2017 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 30.82 | 587 | 18,091 | 34,396 | 33.8 K to 34.4 K (+1.74 %) |
Oct 04 2017 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 32.12 | 564 | 18,116 | 34,232 | 33.7 K to 34.2 K (+1.68 %) |
Oct 03 2017 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.00 | 709 | 0 | 709 | |
Sep 14 2017 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 862 | 0 | 862 | 0 to 862 |
Sep 14 2017 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 825 | 0 | 825 | 0 to 825 |
Jun 16 2017 | TWI | TITAN INTERNATIONA ... | RACHESKY MARK H MD | Director | Option Exercise | A | 11.79 | 20,000 | 235,800 | 20,000 | |
May 24 2017 | EMIS | EMISPHERE TECHNOLO ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.47 | 40,000 | 18,800 | 40,000 | |
Apr 04 2017 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 24.55 | 1,796 | 44,092 | 32,933 | 31.1 K to 32.9 K (+5.77 %) |
Apr 04 2017 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 26.64 | 1,655 | 44,089 | 32,792 | 31.1 K to 32.8 K (+5.32 %) |
Mar 02 2017 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | M | 0.00 | 5,934 | 0 | 0 | |
Mar 02 2017 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | M | 0.00 | 5,933 | 0 | 21,465 | 15.5 K to 21.5 K (+38.20 %) |
Jan 04 2017 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.00 | 996 | 0 | 996 | |
Dec 15 2016 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 30.94 | 5,000 | 154,700 | 5,000 | |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 11,874,474 | 0 | 11,874,474 | 0 to 11.9 M |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 11,874,474 | 0 | 11,874,474 | 0 to 11.9 M |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | J | 0.00 | 23,748,947 | 0 | 0 | 23.7 M to 0 (-100.00 %) |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 1,746,222 | 0 | 1,746,222 | 0 to 1.7 M |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 1,746,222 | 0 | 1,746,222 | 0 to 1.7 M |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | J | 0.00 | 3,492,443 | 0 | 0 | 3.5 M to 0 (-100.00 %) |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 693,138 | 0 | 693,138 | 0 to 693.1 K |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 693,138 | 0 | 693,138 | 0 to 693.1 K |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | J | 0.00 | 1,386,275 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 93,309 | 0 | 93,309 | 0 to 93.3 K |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 93,309 | 0 | 93,309 | 0 to 93.3 K |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | J | 0.00 | 186,617 | 0 | 0 | 186.6 K to 0 (-100.00 %) |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 698,384 | 0 | 698,384 | 0 to 698.4 K |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 698,384 | 0 | 698,384 | 0 to 698.4 K |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | J | 0.00 | 1,396,767 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 432 | 0 | 432 | 0 to 432 |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 432 | 0 | 432 | 0 to 432 |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | J | 0.00 | 865 | 0 | 0 | 865 to 0 (-100.00 %) |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 253 | 0 | 253 | 0 to 253 |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 253 | 0 | 253 | 0 to 253 |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | J | 0.00 | 507 | 0 | 0 | 507 to 0 (-100.00 %) |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 1,221 | 0 | 1,221 | 0 to 1.2 K |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 1,221 | 0 | 1,221 | 0 to 1.2 K |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | J | 0.00 | 2,443 | 0 | 0 | 2.4 K to 0 (-100.00 %) |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 31,137 | 0 | 31,137 | 0 to 31.1 K |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Buy | J | 0.00 | 31,137 | 0 | 31,137 | 0 to 31.1 K |
Dec 12 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | J | 0.00 | 62,274 | 0 | 0 | 62.3 K to 0 (-100.00 %) |
Oct 04 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 20.30 | 1,646 | 33,414 | 62,274 | 60.6 K to 62.3 K (+2.71 %) |
Oct 04 2016 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.00 | 1,365 | 0 | 1,365 | |
Sep 15 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 2,443 | 0 | 2,443 | 0 to 2.4 K |
Jul 05 2016 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.00 | 2,673 | 0 | 2,673 | |
Jun 09 2016 | TWI | TITAN INTERNATIONA ... | RACHESKY MARK H MD | Director | Option Exercise | A | 7.00 | 20,000 | 139,900 | 20,000 | |
May 27 2016 | EMIS | EMISPHERE TECHNOLO ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.78 | 40,000 | 31,160 | 40,000 | |
Apr 05 2016 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.00 | 899 | 0 | 899 | |
Apr 05 2016 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Grant | A | 12.52 | 1,597 | 19,994 | 15,532 | 13.9 K to 15.5 K (+11.46 %) |
Apr 05 2016 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 21.63 | 3,820 | 82,627 | 59,244 | 55.4 K to 59.2 K (+6.89 %) |
Mar 01 2016 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | M | 0.00 | 7,755 | 0 | 0 | |
Mar 01 2016 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | M | 0.00 | 7,755 | 0 | 13,935 | 6.2 K to 13.9 K (+125.49 %) |
Mar 10 2016 | LORL | LORAL SPACE & ... | RACHESKY MARK H MD | Director | Buy | P | 35.70 | 171,099 | 6,108,234 | 1,211,467 | 1 M to 1.2 M (+16.45 %) |
Mar 10 2016 | LORL | LORAL SPACE & ... | RACHESKY MARK H MD | Director | Buy | P | 35.70 | 2,391 | 85,359 | 154,289 | 151.9 K to 154.3 K (+1.57 %) |
Mar 10 2016 | LORL | LORAL SPACE & ... | RACHESKY MARK H MD | Director | Buy | P | 35.70 | 16,510 | 589,407 | 34,732 | 18.2 K to 34.7 K (+90.60 %) |
Mar 07 2016 | LORL | LORAL SPACE & ... | RACHESKY MARK H MD | Director | Buy | P | 34.00 | 130,575 | 4,439,550 | 1,040,368 | 909.8 K to 1 M (+14.35 %) |
Mar 07 2016 | LORL | LORAL SPACE & ... | RACHESKY MARK H MD | Director | Buy | P | 32.75 | 58,264 | 1,908,146 | 909,793 | 851.5 K to 909.8 K (+6.84 %) |
Mar 07 2016 | LORL | LORAL SPACE & ... | RACHESKY MARK H MD | Director | Buy | P | 34.00 | 1,825 | 62,050 | 151,898 | 150.1 K to 151.9 K (+1.22 %) |
Mar 07 2016 | LORL | LORAL SPACE & ... | RACHESKY MARK H MD | Director | Buy | P | 32.75 | 814 | 26,659 | 150,073 | 149.3 K to 150.1 K (+0.55 %) |
Mar 07 2016 | LORL | LORAL SPACE & ... | RACHESKY MARK H MD | Director | Buy | P | 34.00 | 12,600 | 428,400 | 1,133,569 | 1.1 M to 1.1 M (+1.12 %) |
Mar 07 2016 | LORL | LORAL SPACE & ... | RACHESKY MARK H MD | Director | Buy | P | 32.75 | 5,622 | 184,121 | 1,120,969 | 1.1 M to 1.1 M (+0.50 %) |
Jan 05 2016 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.00 | 3,535 | 0 | 3,535 | |
Dec 10 2015 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 10.60 | 5,000 | 53,000 | 5,000 | |
Nov 13 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | S | 39.02 | 7,861,014 | 306,736,766 | 23,748,947 | 31.6 M to 23.7 M (-24.87 %) |
Nov 13 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | S | 39.02 | 1,156,015 | 45,107,705 | 3,492,443 | 4.6 M to 3.5 M (-24.87 %) |
Nov 13 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | S | 39.02 | 458,864 | 17,904,873 | 1,386,275 | 1.8 M to 1.4 M (-24.87 %) |
Nov 13 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | S | 39.02 | 61,771 | 2,410,304 | 186,617 | 248.4 K to 186.6 K (-24.87 %) |
Nov 13 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | S | 39.02 | 426,336 | 16,635,631 | 1,396,767 | 1.8 M to 1.4 M (-23.39 %) |
Oct 05 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 37.15 | 748 | 27,788 | 55,424 | 54.7 K to 55.4 K (+1.37 %) |
Oct 02 2015 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.00 | 2,457 | 0 | 2,457 | |
Sep 17 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Grant | A | 0.00 | 1,298 | 0 | 1,298 | 0 to 1.3 K |
Jul 24 2015 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | P | 18.15 | 136,745 | 2,481,662 | 14,980,528 | 14.8 M to 15 M (+0.92 %) |
Jul 24 2015 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | P | 18.45 | 327,455 | 6,040,235 | 14,843,783 | 14.5 M to 14.8 M (+2.26 %) |
Jul 24 2015 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | P | 18.77 | 335,800 | 6,301,925 | 14,516,328 | 14.2 M to 14.5 M (+2.37 %) |
Jul 02 2015 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.00 | 1,381 | 0 | 1,381 | |
Jun 10 2015 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | P | 25.26 | 229,000 | 5,785,479 | 14,180,528 | 14 M to 14.2 M (+1.64 %) |
Jun 10 2015 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | P | 24.64 | 350,000 | 8,622,530 | 13,951,528 | 13.6 M to 14 M (+2.57 %) |
Jun 10 2015 | NAV | NAVISTAR INTERNATI ... | RACHESKY MARK H MD | Director | Buy | P | 23.98 | 346,000 | 8,298,533 | 13,601,528 | 13.3 M to 13.6 M (+2.61 %) |
Jun 08 2015 | TWI | TITAN INTERNATIONA ... | RACHESKY MARK H MD | Director | Option Exercise | A | 11.03 | 20,000 | 220,600 | 20,000 | |
May 26 2015 | EMIS | EMISPHERE TECHNOLO ... | RACHESKY MARK H MD | Director | Option Exercise | A | 0.50 | 40,000 | 20,088 | 40,000 | |
Apr 30 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | S | 31.60 | 826,075 | 26,103,970 | 31,609,961 | 32.4 M to 31.6 M (-2.55 %) |
Apr 30 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | S | 31.60 | 121,480 | 3,838,768 | 4,648,458 | 4.8 M to 4.6 M (-2.55 %) |
Apr 30 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | S | 31.60 | 48,220 | 1,523,752 | 1,845,139 | 1.9 M to 1.8 M (-2.55 %) |
Apr 30 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | S | 31.60 | 6,491 | 205,116 | 248,388 | 254.9 K to 248.4 K (-2.55 %) |
Apr 30 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | S | 31.60 | 48,584 | 1,535,254 | 1,859,103 | 1.9 M to 1.9 M (-2.55 %) |
Apr 14 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | S | 31.60 | 7,861,014 | 248,408,042 | 32,436,036 | 40.3 M to 32.4 M (-19.51 %) |
Apr 14 2015 | LGF | LIONS GATE ENTERTA ... | RACHESKY MARK H MD | Director | Sell | S | 31.60 | 1,156,015 | 36,530,074 | 4,769,938 | 5.9 M to 4.8 M (-19.51 %) |